ruboxistaurin has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, X; Luo, S; Pang, C; Qin, H; Wen, L; Zhang, X; Zhu, B | 1 |
1 other study(ies) available for ruboxistaurin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Ruboxistaurin maintains the bone mass of subchondral bone for blunting osteoarthritis progression by inhibition of osteoclastogenesis and bone resorption activity.
Topics: Animals; Bone Density; Bone Remodeling; Bone Resorption; Cells, Cultured; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Femur; Indoles; Male; Maleimides; Mice; Mice, Inbred C57BL; Osteoarthritis; Osteoclasts; Osteogenesis | 2020 |